Kenneth Barr

North America. North America Legal Chronicle. April 13, 2021

Entrada Therapeutics’ $116 Million Series B Financing

By Martina Bellini

White & Case LLP advised Qatar Investment Authority on the deal. Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, participated in a US$116...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Citigroup’s €2.5 Billion Notes Offering

KDX’s Inaugural Fund

Golub Capital Partners’ Reset of Golub Capital Partners CLO 65(M)-R

Laticínio São Vicente’s Judicial Restructuring

Éxes Securitizadora’s R$100 Million CRA Issuance

Garanhuns’ R$500 Million Commercial Notes Issuance

Vestum’s Acquisition Of Nortech Management Holdings

DRC Savills Investment Management’s Refinancing and Capex Facility for the Redevelopment of Fitzroy House

Beroe’s Acquisition Of AI Start-Up Nnamu

Tanmiya Capital Ventures’ Investment in El Abd Patisserie

Neosky’s Acquisition of a Boeing 737-800 Aircraft from AMC

Red Med Private Equity’s Investment in Granal

Daewoo Engineering & Construction Co., Ltd’s $155 Million Syndicated Financing

ShopUp’s Merger with Sary Technology to Form SILQ

Umm Al Qura Development and Construction’s Initial Public Offering

Intermediate Capital Group’s Acquisition of SuperChoice Group

Chagee Holdings’ Initial Public Offering

Accent Group’s Strategic Transaction with Frasers Group

Thompson Coburn Welcomes Kimberly Rennick as Chief Business Development & Marketing Officer

Palma Strengthens Compliance and Public Law & Regulatory-Free Competition Areas

LawaL Legal and Tax Advisory achieves Certification on Gender Equality from ANCIS

TozziniFreire Consolidates its Transactional Strategy and Hires Carlos Mello and Mirella Mie Abe as New Partners for the Corporate Team

Milbank Expands Real Estate Practice with Addition of Alex Meirowitz in New York

Fenwick Deepens White Collar & Investigations Team with Arrival of Former SDNY Unit Chief Noah Solowiejczyk

Entrada Therapeutics’ $116 Million Series B Financing

Standard 1 Year Membership Required